Chroma hires Jenny Marlowe as CDO

ARTICLE | Management Tracks

Plus: William Elder named CFO of CervoMed, and updates from Xspray and Senti

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst   

May 20, 2024 11:58 PM UTC

Genomic medicine company Chroma Medicine Inc. hired Jenny Marlowe as chief development officer. Marlowe was CSO at Solid Biosciences Inc. (NASDAQ:SLDB) and VP of preclinical and translational development at bluebird bio Inc. (NASDAQ:BLUE).

CervoMed Inc. (NASDAQ:CRVO) said William Elder will become CFO on June 1, while retaining his role as general counsel. Elder succeeds CFO William Tanner, who will continue as a consultant to the age-related neurological disease company. …